We don't cater to customers in UAE, we only ship internationally.

Sipmax International

  • Hqkast 200 Tablets
  • Hqkast 200 Tablets

Hqkast 200 Tablets

Hqkast 200 Tablets HQKAST-200 contains Hydroxychloroquine Sulphate, an aminoquinoline derivative with antimalarial, anti-inflammatory, and immunomodulatory properties. In autoimmune conditions, it accumulates within intracellular lysosomes and raises the endosomal/lysosomal pH, thereby interfering with antigen processing, inhibiting major histocompatibility complex (MHC) class II presentation, and suppressing Toll-like receptor (TLR) signaling (specifically TLR7 and TLR9). This leads to decreased activation of dendritic cells and reduced production of pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). As an antimalarial, it concentrates in erythrocyte digestive vacuoles of Plasmodium parasites, preventing the polymerization of toxic heme into inert hemozoin, resulting in parasite cell destruction. HQKAST-200 is indicated for the treatment of rheumatoid arthritis, systemic lupus erythematosus (SLE), discoid lupus erythematosus, and uncomplicated malaria caused by susceptible strains.

Read more
Brand HQKAST
Storage Temperature Store in a dry place, protected from light and moisture at a temperature not exceeding 30°C (86°F)
Prescription Needed Yes
Composition Hydroxychloroquine Sulphate
Strength 200 mg
Form Tablets
Pack Size 100 Tablets (10 x 10 Tablets)
Packaging Blister Strips
Country of Origin Made In India
Manufacturer Aprazer Healthcare Pvt. Ltd.

Hqkast 200 Tablets

Hqkast 200 Tablets HQKAST-200 contains Hydroxychloroquine Sulphate, an aminoquinoline derivative with antimalarial, anti-inflammatory, and immunomodulatory properties. In autoimmune conditions, it accumulates within intracellular lysosomes and raises the endosomal/lysosomal pH, thereby interfering with antigen processing, inhibiting major histocompatibility complex (MHC) class II presentation, and suppressing Toll-like receptor (TLR) signaling (specifically TLR7 and TLR9). This leads to decreased activation of dendritic cells and reduced production of pro-inflammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha). As an antimalarial, it concentrates in erythrocyte digestive vacuoles of Plasmodium parasites, preventing the polymerization of toxic heme into inert hemozoin, resulting in parasite cell destruction. HQKAST-200 is indicated for the treatment of rheumatoid arthritis, systemic lupus erythematosus (SLE), discoid lupus erythematosus, and uncomplicated malaria caused by susceptible strains.

Related Products